Baloxavir is a potent antiviral medication classified as an RNA polymerase inhibitor, utilized for the clinical treatment of influenza A and influenza B infections. This category encompasses a comprehensive… Read more
Baloxavir is a potent antiviral medication classified as an RNA polymerase inhibitor, utilized for the clinical treatment of influenza A and influenza B infections. This category encompasses a comprehensive range of reference standards, including the active pharmaceutical ingredient, its known impurities such as dichloromethyl methyl carbonate and benzyloxy triazinedione, and stable isotope-labelled analogues like Baloxavir-D5. Pharmaceutical laboratories and researchers require these high-quality compounds to perform rigorous impurity profiling and method validation. Stable isotope-labelled standards are particularly essential for accurate quantification in mass spectrometry-based analytical testing, ensuring reliable results during quality control assays. By providing access to these specialized reference materials, this collection supports the development, stability testing, and regulatory compliance of antiviral therapeutic products, ensuring consistent performance throughout the drug lifecycle.